Get the Stockscreener App
22.93
0.73%
0.04
Catalyst Pharmaceuticals Inc Stock (CPRX) Latest News
Sanctuary Advisors LLC Has $1.24 Million Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates - MSN
Catalyst Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Catalyst Pharmaceuticals (NASDAQ:CPRX) Shares Gap UpHere's What Happened - MarketBeat
Catalyst Pharmaceuticals' (CPRX) "Overweight" Rating Reaffirmed at Stephens - MarketBeat
Oppenheimer Adjusts Price Target on Catalyst Pharmaceuticals to $32 From $31, Maintains Outperform Rating - Marketscreener.com
Ieq Capital LLC Invests $313,000 in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Principal Financial Group Inc. Grows Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Earnings call transcript: Catalyst Pharmaceuticals Q4 2024 beats expectations By Investing.com - Investing.com Australia
Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Catalyst Pharmaceuticals Reports Record 2024 Financial Results - TipRanks
Catalyst Pharmaceuticals Reports Strong Growth Amid Challenges - TipRanks
Catalyst Pharmaceuticals (NASDAQ:CPRX) Announces Quarterly Earnings Results - MarketBeat
Catalyst Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today - MSN
Catalyst Pharmaceuticals Inc (CPRX) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Catalyst Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
Earnings call transcript: Catalyst Pharmaceuticals Q4 2024 beats expectations - Investing.com
Catalyst Pharma Forecasts Double-Digit Revenue Growth For 2025 - RTTNews
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Position Increased by Rhumbline Advisers - Defense World
Investor Network: Catalyst Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Catalyst Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Catalyst Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times
Earnings Flash (CPRX) Catalyst Pharmaceuticals Reports Q4 Revenue $141.8M, vs. FactSet Est of $134.2M - Marketscreener.com
Catalyst Pharmaceuticals Reports Record Fourth Quarter and - GlobeNewswire
How Catalyst's Three-Product Strategy Drove 23.5% Revenue Growth to Record $491.7M in 2024 - StockTitan
CATALYST PHARMACEUTICALS, INC. SEC 10-K Report - TradingView
Sanctuary Advisors LLC Has $1.24 Million Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Catalyst Pharmaceuticals Inc (CPRX) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Catalyst Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Brokerages Set Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) PT at $32.25 - Defense World
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Cautious Investors Not Rewarding Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Performance Completely - Simply Wall St
Allspring Global Investments Holdings LLC Boosts Stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Catalyst Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Stake Raised by Allspring Global Investments Holdings LLC - Defense World
Catalyst Pharmaceuticals (CPRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Allspring Global Investments Holdings LLC Has $8.71 Million Holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Catalyst Pharmaceuticals stock hits all-time high of $24.44 - MSN
Catalyst Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374% - Yahoo Finance
Yousif Capital Management LLC Has $903,000 Stock Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - Defense World
Advisors Preferred LLC Takes $1.08 Million Position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 - GlobeNewswire
Catalyst Pharmaceuticals to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025 - Nasdaq
Earnings Alert: Catalyst Pharmaceuticals Sets Key Q4 Financial Results DateStrategic Updates Expected - StockTitan
abrdn plc Acquires Shares of 484,666 Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) - MarketBeat
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares Bought by Spire Wealth Management - MarketBeat
Catalyst Pharmaceuticals (NASDAQ:CPRX) Raised to "Strong-Buy" at Baird R W - MarketBeat
Short Interest in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Rises By 12.5% - MarketBeat
Catalyst Pharmaceuticals (NASDAQ:CPRX) Coverage Initiated by Analysts at Robert W. Baird - MarketBeat
Catalyst Remains a Big Money Favorite - FX Empire
3.91%
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):